Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine
Open Access
- 22 December 2009
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 2 (3) , 236-249
Abstract
We used Neuromolecular Imaging (NMI) and trademarked BRODERICK PROBE® mini-implantable biosensors, to selectively and separately detect neurotransmitters in vivo, on line, within seconds in the dorsal striatal brain of the Parkinson’s Disease (PD) animal model. We directly compared our results derived from PD to the normal striatal brain of the non-Parkinson’s Disease (non-PD) animal. This advanced biotechnology enabled the imaging of dopamine (DA), serotonin (5-HT), homovanillic acid (HVA) a metabolite of DA, L-tryptophan (L-TP) a precursor to 5-HT and peptides, dynorphin A 1-17 (Dyn A) and somatostatin (somatostatin releasing inhibitory factor) (SRIF). Each neurotransmitter and neurochemical was imaged at a signature electroactive oxidation/half-wave potential in dorsal striatum of the PD as compared with the non-PD animal. Both endogenous and bromocriptine-treated neurochemical profiles in PD and non-PD were imaged using the same experimental paradigm and detection sensitivities. Results showed that we have found significant neurotransmitter peptide biomarkers in the dorsal striatal brain of endogenous and bromocriptine-treated PD animals. The peptide biomarkers were not imaged in dorsal striatal brain of non-PD animals, either endogenously or bromocriptine-treated. These findings provide new pharmacotherapeutic strategies for PD patients. Thus, our findings are highly applicable to the clinical treatment of PD.Keywords
This publication has 23 references indexed in Scilit:
- Abstract of "A Clinical Trial of an Advanced Diagnostic Biomedical Device for Epilepsy Patients"Journal of Long-Term Effects of Medical Implants, 2008
- Studies of oxidative stress mechanisms using a morphine / ascorbate animal model and novel N-stearoyl cerebroside and laurate sensorsJournal of Neural Transmission, 2007
- Whole-body imaging with fluorescent proteinsNature Protocols, 2006
- The multiple uses of fluorescent proteins to visualize cancer in vivoNature Reviews Cancer, 2005
- Monoamine neurotransmitters in resected hippocampal subparcellations from neocortical and mesial temporal lobe epilepsy patients:Brain Research, 2000
- Potential of Opioid Antagonists in the Treatment of Levodopa-Induced Dyskinesias in Parkinson??s DiseaseDrugs & Aging, 1996
- A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- In vivo voltammetric studies on release mechanisms for cocaine with γ-butyrolactonePharmacology Biochemistry and Behavior, 1991
- Characterizing stearate probes in vitro for the electrochemical detection of dopamine and serotoninBrain Research, 1989